Both in Surgical Instruments
Accuray Incorporated vs Cytosorbents
Over the past year ARAY returned −89.4% and CTSO returned −73.6%; their daily moves had a correlation of 0.01.
ARAY −89.4% CTSO −73.6%Growth of $1, one year, split-adjusted
| Metric | ARAY | CTSO |
|---|---|---|
| Price | $0.1480 | $4.12 |
| Market cap | $17.7M | $13.0M |
| Today | +5.71% | −9.25% |
| 1 month | −47.3% | +1.7% |
| 6 months | −67.8% | −66.8% |
| Year to date | −82.1% | −67.8% |
| 1 year | −89.3% | −73.7% |
| Revenue growth (YoY) | −20.9% | +0.2% |
| Gross margin | 34.8% | 73.2% |
| Net margin | −1.9% | −45.9% |
| P/E (TTM) | — | — |
| Price / sales | 0.0× | 0.3× |
| Net cash | -$107.2M | -$12.8M |
| Dividend yield | — | — |
| Volatility (60d) | 106.6% | 881.1% |
| Short % of float | 5.9% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).